News
Suven Life Sciences reports consolidated net loss of Rs 106.94 crore in the September 2026 quarter
05-Nov-2026 | 16:22
Sales rise 30.43% to Rs 1.20 crore
Net Loss of Suven Life Sciences reported to Rs 106.94 crore in the quarter ended September 2026 as against net loss of Rs 77.31 crore during the previous quarter ended September 2025. Sales rose 30.43% to Rs 1.20 crore in the quarter ended September 2026 as against Rs 0.92 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 1.20 | 0.92 | 30 |
| OPM % | -9242.50 | -8670.65 | - |
| PBDT | -104.64 | -75.99 | -38 |
| PBT | -106.94 | -77.31 | -38 |
| NP | -106.94 | -77.31 | -38 |
Powered by Capital Market - Live News